Navigation Links
Misonix Announces New Distribution Agreement For Denmark
Date:4/2/2013

FARMINGDALE, N.Y., April 2, 2013 /PRNewswire/ -- Misonix, Inc. (NasdaqGM: MSON), a surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products worldwide for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, has entered into a new, three year, exclusive distribution agreement with Maersk-Andersen AS, based in Randers, Denmark, for the distribution of the Misonix® BoneScalpel™ Ultrasonic Bone Cutting System.  The agreement provides Maersk-Andersen with the right to sell throughout Denmark.  Included in the agreement are annual minimum purchase requirements.  Product training has been completed and open market sales have commenced.

Maersk-Andersen, known for their focused market presence in neuro, spine and other orthopedic surgeries, is well prepared and strategically well positioned to successfully introduce high tech products, like the BoneScalpel, to the Danish market.  Their commitment to clinical education and product service is well known and separates them from the competition.

The Misonix BoneScalpel is a novel ultrasonic osteotome (bone cutting device) used for safe, tissue-selective bone dissection that encourages non-fragmented bone removal and refined osteotomies while sparing elastic soft tissue structures.  Most users report that the surgical field is relatively clean and bloodless.  Loss of viable bone is minimal and controllable.  The BoneScalpel has been used extensively for bone removal in spine surgery and maxillo-facial reconstructive surgery.

"It is our pleasure to add Maersk-Andersen to our distribution organization in Europe; their presence in a sophisticated healthcare market like Denmark could add measurably to our sales success.  Their history of successfully introducing cutting edge products to the Danish market is well known to us," said Michael A. McManus, Jr. , President and Chief Executive Officer of Misonix. 

About Misonix
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.

Safe Harbor Statement
With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.Investor Relations ContactsMisonix Contact:

Lytham Partners, LLCRichard Zaremba

Robert Blum, Joe Dorame, Joe Diaz631-694-9555

602-889-9700invest@misonix.com

mson@lythampartners.com


'/>"/>
SOURCE Misonix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Announces New Distribution Agreement For Panama
2. Misonix And SIAD Healthcare Renew Distribution Agreement For Italy
3. Misonix Exhibits at Major Worldwide Spine Conference
4. Misonix Adds Industry Veteran To Management Team
5. Misonix Participates In Cleveland Spine Review
6. Misonix And Soelim Create New Distribution Alliance For South Korea
7. Misonix Inks New Distribution Agreement For Croatia And Slovenia
8. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
9. Misonix Adds 6 Spine Sales Agencies In The U.S.
10. Misonix Product Featured At Neurosurgery Congress
11. Misonix Reports Strong Revenue Increases for the Three Months and Full-Year Ended June 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Feb. 22, 2017  Corin Group announced today the ... used to treat patients with both a massive rotator ... The condition, known as cuff tear arthropathy, causes pain ... The Humelock Reversed Shoulder System, which was ... company based near Lyon, France , ...
(Date:2/22/2017)... Research and Markets has announced the addition of the ... to their offering. ... Dermatological conditions are one of the most ... US population suffers from at least one active skin condition. ... has remained saturated with established and generic products. However, the ...
(Date:2/22/2017)... 22, 2017 Research and Markets has ... by Drug Molecule (Biologic, Small Molecule Drugs), By Route of ... Blockers) Outlook 2022" report to their offering. ... The global psoriasis ... 2016-2022 This report provides a detailed analysis of ...
Breaking Medicine Technology:
(Date:2/22/2017)... Addison, TX (PRWEB) , ... February 22, 2017 ... ... announced the launch of ProGen™ PRP, the latest innovation in the delivery of ... orthopedics, wound care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The SeniorCare Investor ... 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A recording of ... part of the Interactive Webinar Series. , If you want to find out what ...
(Date:2/22/2017)... ... 22, 2017 , ... FPS is a nonprofit mental health ... in 1977, our organization was at the forefront in working with veterans with ... were evident and served as the catalyst for the establishing the agency. , ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... by itself - the Vector™ Series Multi-Cook Oven offers up to four ovens ... featuring exclusive Structured Air Technology™ for unmatched evenness in cooking. Alto-Shaam has partnered ...
(Date:2/21/2017)... ... 21, 2017 , ... Robins & Morton celebrated the grand ... Feb. 21. , The celebration began with a ribbon cutting event at 10:30 ... team and tribal leadership. , Choctaw Nation Durant Regional Medical Clinic is ...
Breaking Medicine News(10 mins):